XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisition of Ascyrus (Purchase Price Allocation) (Details) - USD ($)
$ in Thousands
Sep. 02, 2020
Sep. 30, 2020
Dec. 31, 2019
Consideration      
Contingent consideration   $ 55,407
Purchase Price Allocation      
Goodwill   253,995 $ 186,697
Ascyrus Medical LLC [Member]      
Consideration      
Cash paid for acquisition $ 63,660    
Common stock issued 20,000    
Contingent consideration 55,407    
Fair value of total consideration 139,067    
Purchase Price Allocation      
Cash and cash equivalents 4,017    
Intangible assets 72,600    
Net other assets/liabilities acquired (274)    
Goodwill 62,724 $ 62,700  
Total purchase consideration $ 139,067